Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Alessandria
Clinical trial register · Italy

Clinical Trials in Alessandria, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Italiana Linfomi - ETS20 Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria19 AstraZeneca8 Merck Sharp & Dohme LLC7 Gruppo Italiano Malattie EMatologiche dell'Adulto6
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Alessandria

164 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Recruiting
VENtilation Modalities During Transport of PostoperatIve CRITically Ill Patients to the ICU
NCT07646249Respiration, Artificial, Positive-Pressure Respiration, Postoperative Complications (Cardiopulmonary), Postoperative Complications
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
Observational
800
Alessandria
2026-09-07
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
600
Alessandria
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
518
Alessandria, Avellino, Aviano, Bergamo, Brescia, Cagliari, Candiolo, Catania
2026-07-10
Not yet open
Emergency and Urgent Care Indicators in Piedmont
NCT07606209Emergency Departments
Mario Negri Institute for Pharmacological Research
Observational
650,000
Alessandria
2026-07-01
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Not yet open
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
NCT07463781Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS
Observational
100
Alessandria, Ancona, Brescia, Palermo, Reggio Calabria, Roma, Taranto, Udine
2026-05
Recruiting
Gruppo Oncologico Italia Meridionale
Phase 2
150
Alessandria, Ancona, Aviano, Caserta, Castellana Grotte, Catania, Catanzaro, Florence
2026-03-20
Recruiting
Eli Lilly and Company
Phase 4
150
Alessandria, Florence, Messina, Monza, Perugia, Rome, Terni
2026-03-09
Recruiting
Mechanical Ventilation in Surgical Patients
NCT06296277Surgery, Ventilator Lung, Postoperative Complications
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
10,000
Alessandria
2026-03-01
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Alessandria, Brescia, Milan, Pisa, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2026-02-04
Recruiting
Novartis Pharmaceuticals
Observational
50
Alessandria, Avellino, Brescia, Florence, Genova, Milan, Palermo, Roma
2026-01-13
Recruiting
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations
NCT06846879Quality of Care, Evaluation, Emergency Department, Appropriateness
Mario Negri Institute for Pharmacological Research
Observational
240,000
Alessandria, Cuneo, Novara, Novi Ligure, Orbassano, Rivoli, Torino
2026-01-05
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Alessandria, Ancona, Bergamo, Bologna, Catania, Meldola, Livorno, Legnano
2025-12-22
Recruiting
Incyte Corporation
Phase 3
466
Alba, Alessandria, Aviano, Bologna, Florence, Lecco, Milan, Mirano
2025-12-09
Recruiting
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768Polycythemia Vera, Thrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
678
Pavia, Vicenza, Alessandria, Bergamo, Bologna, Brescia, Florence, Milan
2025-12-01
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Monza, Pesaro, Alessandria, Bergamo, Bologna, Brescia, Candiolo, Florence
2025-11-25
By invitation
Istituto di Studi Superiori Musicali (ISSM) Conservatorio Antonio Vivaldi di Alessandria
Not applicable
24
Alessandria
2025-11-12
Recruiting
Laboratorio Farmaceutico SIT srl
Phase 4
240
Alessandria, Catania, Milan, Roma, Sassari
2025-10-21
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Alessandria, Bari, Bologna, Brescia, Catania, Florence, Milan, Naples
2025-10-17
Recruiting
Nurix Therapeutics, Inc.
Phase 2
100
Alessandria, Bologna, Milan, Ravenna
2025-10-15
Active, closed
A New Crowding Indicator in the Emergency Department
NCT07111624Emergency Department, Crowding
Mario Negri Institute for Pharmacological Research
Observational
828
Brescia, Genova, Ravenna, Roma, Cirié, Orbassano, Vercelli, Alessandria
2025-10-15
Recruiting
Alfasigma S.p.A.
Phase 3
80
Alessandria, Ancona, Milan, Naples, Rome, Trieste
2025-09-29
Recruiting
BioNTech SE
Phase 1/2
880
Alessandria, Catania, Florence, Milan, Roma
2025-09-22
Recruiting
Use of Maltodextrins in the ERAS Preoperative Fasting Protocol in Pediatric Surgery
NCT07686029Preoperative Care, Anxiety, Pediatric Surgery
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
200
Alessandria
2025-09-03
Recruiting
AstraZeneca
Phase 3
800
Alessandria, Aviano, Bari, Bologna, Catania, Florence, Haifa, Milan
2025-08-01
Recruiting
Novartis Pharmaceuticals
Observational
300
Alessandria, Asti, Bergamo, Brescia, Catania, Meldola, Cona, Foggia
2025-07-30
Recruiting
Celgene
Phase 3
400
Bologna, Meldola, Rozzano, Pisa, Alessandria, Naples, Torino
2025-07-28
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
120
Alessandria
2025-07-17
Active, closed
Incyte Corporation
Phase 3
9
Alessandria, Ancona, Bergamo, Bologna, Brescia, Catania, Florence, Genova
2025-06-04
Not yet open
Procalcitonin Aided Antimicrobial Therapy vs Standard of Care
NCT06960044Lower Respiratory Tract Infection (LRTI)
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
108
Alessandria
2025-06-01
Active, closed
Impact of Covid-19 on Syphilis
NCT07150871Syphilis, COVID - 19, HIV (Human Immunodeficiency Virus), Retrospective Studies
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
240
Alessandria
2025-05-28
Recruiting
Eikon Therapeutics
Phase 2/3
740
San Giovanni Rotondo, Alessandria, Messina, Milan, Modena, Padova, Trento, Genoa
2025-05-22
Recruiting
SecuraBio
Phase 3
124
Alessandria, Bergamo, Bologna, Naples, Rome
2025-05-19
Recruiting
Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
NCT06588205Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS
Observational
200
Alessandria, Ancona, Bari, Brescia, Candiolo, Castelfranco Veneto, Catania, Civitanova Marche
2025-05-05
Recruiting
Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
NCT07670975Crohn Disease Colitis, Colitis, Ulcerative, Inflammatory Bowel Diseases
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
50
Alessandria
2025-05-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2
594
Meldola, Rozzano, Palermo, Alessandria, Milan, Naples, Reggio Emilia
2025-04-11
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
47
Alessandria, Pescara, Ancona, Avellino, Aviano, Brescia, Florence, Milan
2025-04-09
Active, closed
Sanofi
Phase 2
204
Genoa, Milan, Rozzano, Naples, Padua, Rome, Turin, Alessandria
2025-03-28
Recruiting
AstraZeneca
Phase 3
11,300
Alessandria, Bari, Bergamo, Brescia, Chiavari, Cona, Foggia, Milan
2025-03-14
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
500
Alessandria
2025-02-27
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Alessandria, Bari, Bologna, Florence, Genova, Messina, Milan, Modena
2025-02-26
Recruiting
Landiolol in Mitral Valve Surgery
NCT06793670Cardiac Failure, Low Cardiac Output Syndrome
DrugLandiolol
Università Vita-Salute San Raffaele
Phase 4
1,500
Alessandria, Torino, Catania, Florence, Foggia, Genova, Milan, Palermo
2025-01-28
Recruiting
Incyte Corporation
Phase 3
240
Alessandria, Ancona, Bari, Brescia, Catania, Genova, Milan, Naples
2025-01-21
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
290
Alessandria, Padova, Perugia, Rome, Siena, Verona
2025-01-15
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
212
Alessandria, Ancona, Ascoli Piceno, Bari, Biella, Bologna, Bolzano, Ferrara
2024-12-13
Not yet open
Italian Data Registry of Patients Undergoing Peripheral Nerve Block Performed in the Emergency Departments
NCT06707558Emergency, Point of Care Ultrasound (POCUS), Anesthesia, Acute Pain
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
500
Alessandria
2024-12-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
59
Alessandria, Bologna, Catania, Cosenza, Ferrara, Meldola, Milan, Padova
2024-12-09
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Alessandria, Bologna, Busto Arsizio, Milan, Roma
2024-11-27
Active, closed
Istituto Oncologico Veneto IRCCS
Phase 2
41
Bergamo, Roma, Rozzano, Aviano, Alessandria, Ferrara, Padova, Parma
2024-11-06
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Alessandria, Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Foggia
2024-11-04
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Candiolo, Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Milan
2024-10-23
Active, closed
Use of Cannabis Oil in Fibromyalgia
NCT07194018Fibromyalgia, Pain Management, Cannabis, Retrospective Studies
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
65
Alessandria
2024-10-19
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples
2024-10-14
Active, closed
Amgen
Phase 1
49
Alessandria, Milan, Rozzano (MI), Verona
2024-09-17
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Alessandria, Asti, Bari, Bergamo, Bologna, Cagliari, Chieri, Chieti
2024-08-30
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
DrugsVolrustomig·Adrucil·Paclitaxel·Cisplatin
AstraZeneca
Phase 2
257
Alessandria, Bergamo, Orbassano
2024-08-22
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
120
Alessandria
2024-08-19
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Recruiting
NovoCure GmbH
Phase 3
734
Alessandria, Bergamo, Ferrara, Meldola, Pesaro, Roma, Rome, Siena
2024-07-31
Recruiting
ARCAGY/ GINECO GROUP
Phase 3
250
Alessandria, Bologna, Florence, Lecco, Milan, Venice
2024-07-30
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Florence, Alessandria, Bologna, Milan, Pavia, Roma, Varese
2024-07-16
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
120
Alessandria
2024-07-03
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Alessandria, Bologna, Catania, Cuneo, Ferrara, Florence, Genova, Milan
2024-06-26
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Forlì, Milan
2024-06-03
Active, closed
Windtree Therapeutics
Phase 1/2
20
Alessandria, Brescia, Milan, Turin
2024-06-01
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Recruiting
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
NCT06351631Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis
DrugBomedemstat
Merck Sharp & Dohme LLC
Phase 3
400
Florence, Alessandria, Bologna, Varese
2024-05-23
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Active, closed
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
20
Alessandria
2024-05-06
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
130
Alessandria, Ancona, Avellino, Aviano, Brescia, Castelfranco Veneto, Florence, Milan
2024-04-18
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Alessandria, Bari, Bergamo, Brescia, Catania, Cona, Florence, Messina
2024-04-11
Active, closed
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
329
Alessandria
2024-03-23
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Alessandria, Bergamo, Bologna, Florence, Milan, Roma
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
90
Alessandria, Bergamo, Bologna, Florence, Milan, Roma
2024-03-13
Recruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
NCT06049654Aortic Valve Stenosis, Structural Valve Deterioration
Fundación EPIC
Not applicable
104
Alessandria, Brescia, Perugia
2024-02-01
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Alessandria, Bologna, Milan
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Cona, Meldola, Milan, Florence, Pisa, Castelfranco Veneto, Alessandria, Ancona
2023-12-31
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
1,500
Viagrande, Pescia, Alessandria, Ancona, Avellino, Aviano, Bari, Barletta
2023-12-27
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
190
Sassuolo, Alessandria, Avellino, Aviano, Bari, Biella, Brescia, Cagliari
2023-12-14
Active, closed
AstraZeneca
Phase 3
863
Alessandria, Bari, Bergamo, Milan, Monza, Orbassano, Padova, Parma
2023-11-09
Active, closed
Amgen
Phase 3
633
Crema, Meldola, Taormina, Rozzano, Alessandria, Bari, Bergamo, Florence
2023-11-02
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Alessandria, Chieti, Città di Castello, Empoli, Lecce, Lecco, Legnago, Legnano
2023-10-24
Recruiting
Hoffmann-La Roche
Phase 3
182
Bologna, Bergamo, Milan, Alessandria, Turin
2023-10-22
Recruiting
Acrotech Biopharma Inc.
Phase 3
504
Tricase, Milan, Meldola, Borgo Roma, Alessandria, Genova, Parma, Pavia
2023-10-04
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
654
Alessandria, Biella, Brescia, Catania, Cuneo, Florence, Genova, Meldola
2023-09-19
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Active, closed
AstraZeneca
Observational
151
Alessandria, Ancona, Bari, Barletta, Brindisi, Campobasso, Catania, Catanzaro
2023-08-08
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
Alessandria, Milan, Reggio Emilia
2023-08-08
Recruiting
NovoCure Ltd.
Observational
198
Alessandria, Bergamo
2023-08-01
Recruiting
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure
NCT06918912Diffuse Large B-Cell Lymphoma, High-grade B-cell Lymphoma (HGBCL), B-Cell Lymphoma Treatment, Relapsed or Refractory Lymphoma
DrugLoncastuximab Tesirine
Istituto Clinico Humanitas
Phase 2
50
Alessandria, Bologna, Cuneo, Milan, Rozzano, Roma
2023-06-16
Recruiting
Hoffmann-La Roche
Phase 3
420
Caserta, Meldola, Ravenna, Aviano, Milan, Alessandria, Turin, Misterbianco (CT)
2023-06-07
Not yet open
Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation
NCT05782738Coronary Artery Disease, Coronary Stenosis, Coronary Disease
San Luigi Gonzaga Hospital
Not applicable
361
Cirié, Moncalieri, Alessandria, Cuneo, Turin
2023-06-01
Recruiting
Eli Lilly and Company
Phase 1/2
880
Alessandria, Brescia, Milan, Monza, Pisa, Ravenna, Roma, Verona
2023-04-17
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL, Waldenstrom Macroglobulinemia
Schrödinger, Inc.
Phase 1
98
Alessandria, Milan, Torino, Verona
2023-04-10
Active, closed
Novartis Pharmaceuticals
Observational
242
Alessandria, Ancona, Bari, Bologna, Como, Cosenza, Catania, Florence
2023-03-02
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 1/2
122
Alessandria, Candiolo, Avellino, Aviano, Bari, Brescia, Lecce, Meldola
2023-02-27
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Active, closed
Silence Therapeutics plc
Phase 1/2
69
Alessandria, Meldola
2023-01-26
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
San Giovanni Rotondo, Rho, Rozzano, San Donato Milanese, Negrar, Alessandria, Bologna, Brescia
2023-01-16
Recruiting
GBG Forschungs GmbH
Phase 2
170
Alessandria, Ancona, Carpi, Lecco, Legnago, Milan, Pavia, Udine
2023-01-02
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova
2022-12-21
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS
Observational
150
Alessandria, Ancona, Bari, Brescia, Castelfranco Veneto, Catania, Florence, Messina
2022-12-07
Active, closed
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
128
Alessandria
2022-11-15
Recruiting
Associazione Qol-one
Phase 2
22
Alessandria, Ancona, Avellino, Biella, Catania, Chivasso, Cosenza, Florence
2022-11-03
Active, closed
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
86
Alessandria
2022-10-04
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
429
Bergamo, Milan, Pavia, Varese, Padova, Verona, Vicenza, Alessandria
2022-09-08
Recruiting
European Myeloma Network B.V.
Phase 3
1,594
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Cosenza
2022-09-08
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Alessandria, Bologna, Meldola, Milan, Reggio Emilia
2022-07-22
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsZilovertamab vedotin·Nemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
189
Bologna, Rozzano, Alessandria, Roma
2022-07-21
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Rome, Milan, Palermo, Florence, Alessandria
2022-07-14
Active, closed
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
137
Alessandria
2022-07-05
Recruiting
Priothera SAS
Phase 3
366
Brindisi, Reggio Calabria, San Giovanni Rotondo, Lecce, Roma, Alessandria, Ascoli Piceno, Florence
2022-06-16
Recruiting
Pirfenidone to Prevent Fibrosis in Ards.
NCT05075161Acute Respiratory Distress Syndrome (ARDS)
DrugPirfenidone
Università Vita-Salute San Raffaele
Phase 3
130
Milan, Alessandria, Bari, Brescia, Cagliari, Merano, Palermo, Pisa
2022-06-01
By invitation
Studio TIARA: Alessitimia ed Emicrania Cronica
NCT06891053Migraine, Alexithymia
Azienda Sanitaria Locale di Alessandria
Observational
350
Alessandria
2022-05-30
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
2,500
Alessandria, Arezzo, Baggiovara, Bergamo, Bologna, Brescia, Cagliari, Correggio
2022-01-03
Active, closed
Intradurale Spinal Tumors: Management and Treatment
NCT07488702Spinal Cord Neoplasms, Spinal Neoplasms
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Observational
50
Alessandria
2022-01-01
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
101
Alessandria, Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Castelfranco Veneto
2021-12-03
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
Alessandria, Ancona, Bolzano, Castellanza, Catania, Cremona, Florence, Genoa
2021-09-14
Recruiting
Health-care Quality in Semi-intensive Care Units
NCT04676347Semi-intensive Care Unit, Evaluation, Quality
Mario Negri Institute for Pharmacological Research
Observational
39,000
Milan, Alessandria, Bassano del Grappa, Bologna, Catania, Cesena, Livorno, Lodi
2021-07-01
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Alessandria, Naples, Torino, Vercelli
2021-05-15
Active, closed
Geron Corporation
Phase 3
327
Alessandria, Bologna, Cona, Florence, Genova, Milan, Ravenna, Reggio Calabria
2021-04-12
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Alessandria, Meldola, Ravenna, Milan, Bologna, Genova, Palermo, Potenza
2021-04-08
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 3
430
Brescia, Piacenza, Rionero in Vulture, Alessandria, Ancona, Ascoli Piceno, Aviano, Barletta
2021-03-23
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Viale Orazio Flacco, Monza (MB) -Settore E, Pisa, Rionero in Vulture, Vicenza, Alessandria, Bergamo, Brescia
2021-03-09
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Alessandria, Avellino, Aviano, Bari, Brescia, Candiolo, Catania, Florence
2021-02-23
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Observational
496
Alessandria, Ponderano, Cagliari, Catania, Milan, Palermo, Padova, Pescara
2020-12-01
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Bayer
Phase 4
654
Ferrara, Modena, Parma, Aviano, Rome, Genoa, Milan, Alessandria
2020-11-09
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
321
Cona, Alessandria, Bari, Cagliari, Catania, Catanzaro, Cosenza, Florence
2020-07-24
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
572
Alessandria, Asti, Bari, Bologna, Cagliari, Florence, Milan, Modena
2020-05-29
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Alessandria, Aviano, Bologna, Brescia, Meldola, Milan, Torino
2019-12-16
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Recruiting
Low INR to Minimize Bleeding With Mechanical Valves Trial
NCT03636295Bleeding Post-mechanical Valve Replacement, Thromboembolism Post-mechanical Valve Replacement
DrugWarfarin
Population Health Research Institute
Phase 3
2,625
Lecce, Alessandria, Ancona, Foggia
2019-09-05
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
75
Castelfranco Veneto, Alessandria, Ancona, Avellino, Aviano, Bari, Brescia, Cagliari
2019-07-02
Active, closed
Fondazione EMN Italy Onlus
Phase 3
84
Alessandria, Ancona, Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Cagliari
2019-07-01
Recruiting
Population Health Research Institute
Phase 4
2,270
Milan, Alessandria, Palermo, Piacenza
2019-06-14
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Alessandria, Bologna, Candiolo, Meldola, Milan
2018-06-26
Recruiting
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Not applicable
340
Alessandria, Forlì, Camposampiero, Negrar, Acquaviva delle Fonti, Biella, Brescia, Cremona
2018-06-05
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Alessandria, Arezzo, Aviano, Bergamo, Brescia, Cremona, Florence, Genova
2018-03-23
Recruiting
In-hospital Stellate Ganglion Block for Arrhythmic Storm
NCT05720936Arrhythmic Storm, Electrical Storm, Ventricular Fibrillation, Ventricular Tachycardia
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Alessandria, Bentivoglio, Bologna, Pavia, Voghera, Legnago, Ancona, Asti
2017-11-07
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
Acerta Pharma BV
Phase 3
535
Alessandria, Aviano, Brescia, Florence, Meldola, Milan, Parma, Ravenna
2015-06-26
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 3
128
Milan, Ravenna, Candiolo, Castelfranco Veneto, Terni, Busto Arsizio, Alessandria, Ascoli Piceno
2014-05
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
112
Alessandria, Ancona, Aviano, Biella, Bolzano, Cagliari, Catania, Genova
2013-12
Recruiting
Italian Network MDS Registry
NCT02808858Myelodysplastic-Myeloproliferative Diseases
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
10,000
Alessandria, Ancona, Genova, Parma, Rionero in Vulture, Candiolo, Torino, Asti
2013-09
Active, closed
MedImmune LLC
Phase 2
571
Alessandria, Aviano, Bergamo, Bologna, Candiolo, Genova, Meldola, Milan
2013-05-17
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Alessandria, Ancona, Aviano, Bari, Barletta, Bergamo, Bologna, Bolzano
2012-10
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Alessandria, Naples, Ravenna, Rionero in Vulture, Rome, Verona
2012-04-03
Active, closed
Associazione Qol-one
Phase 2
174
Alessandria, Ancona, Asti, Avellino, Bari, Brindisi, Cagliari, Cosenza
2011-06-11
Rows per page Showing 1–164 of 164
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/alessandria

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 164 of those studies with a site in Alessandria.

How many clinical trials are recruiting in Alessandria?

94 of the 164 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 6 have not yet opened recruitment, 62 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alessandria), 164 studies
PhaseStudiesRecruitingShare
Phase 3573434.8%
Observational553433.5%
Phase 2261215.9%
Not applicable1046.1%
Phase 1/2844.9%
Phase 4543%
Phase 1211.2%
Phase 2/3110.6%

Most active sponsors

Lead sponsors with the most studies (Alessandria)
Lead sponsorStudiesRecruiting
Fondazione Italiana Linfomi - ETS2011
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria199
AstraZeneca86
Merck Sharp & Dohme LLC73
Gruppo Italiano Malattie EMatologiche dell'Adulto63
Mario Negri Institute for Pharmacological Research53
International Extranodal Lymphoma Study Group (IELSG)41
Janssen Research & Development, LLC42
Novartis Pharmaceuticals42
Eli Lilly and Company33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.